Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Launches US Subsidiary

NEW YORK (GenomeWeb) – Cellectis today announced it has established a new subsidiary in New York to serve as the Paris-based firm's US headquarters. Cellectis, Inc. will feature laboratory space to develop engineered chimeric antigen receptor (CAR) T cells for gene editing-based cancer therapy.

The subsidiary will nestle in at the Alexandria Center for Life Science, a biotechnology development hub on Manhattan's East side near the city's major biomedical research centers, including New York University and Rockefeller University. Other tenants at the development include Eli Lilly, Roche, and Pfizer.

"At the Alexandria Center for Life Science, Cellectis is surrounded by renowned academic and medical institutions, leaders from the commercial life sciences industry, and the world's most robust financial markets," Cellectis Founder and CEO André Choulika said in a statement.

Cellectis is developing cancer immunotherapies based on engineered chimeric antigen receptor T cells. The firm said it has more than 15 years of expertise in genome engineering, based on its transcription activator-like effector nuclease, meganuclease, and pulse agile technology.

In January, Cellectis priced an American initial public offering and began trading on the Nasdaq under ticker symbol "CLLS."

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.